대한안과학회 학술대회 발표 연제 초록
 
발표일자: 2013년 11월 1일(금) ~ 11월 3일(일)
발표번호: P(판넬)-020
발표장소: 킨텍스 제2전시장 7B홀
망막중심정맥폐쇄에서 발생한 황반 부종의 베바시주맙 치료 반응 예측인자로서의 스펙트럼 영역 빛간섭단층촬영 소견
연세대학교 의과대학 안과학교실, 시기능개발연구소
박용식, 변석호, 이성철, 이승규, 김성수
목적 : Baseline spectral-domain optical coherence tomography (SD-OCT) morphology in patients with macular edema (ME) following central retinal vein occlusion (CRVO) was evaluated with respect to response to bevacizumab treatment. 방법 : Retrospective, interventional cases series. Twenty-three eyes of 23 patients (11 male, 12 female) with ME due to CRVO had a minimum of 12 months follow-up, with a mean age of 61±17 years at the time of symptom development. All patients were treated with intravitreal injection of 1.25 mg bevacizumab and follow-up examinations were carried out every 4-8 weeks. Reinjections were only performed if ME persisted or recurred. 결과 : Baseline extent of inner nuclear layer (INL) cystic change/swelling was significantly correlated with 1-year best corrected visual acuity (BCVA), duration of ME and number of intravitreal bevacizumab injection (IVB) (p = 0.034, p = 0.006 and p = 0.011, respectively). Baseline logMAR BCVA was positively correlated with 1-year logMAR BCVA, duration of ME and number of IVB (p = 0.001, p = 0.043 and p = 0.045, respectively). Central retinal thickness (CRT) was not correlated with 1-year BCVA, duration of ME and number of IVB (p = 0.461, p = 0.265 and p = 0.459). 결론 : In CRVO patients, baseline extent of INL cystic change/swelling and IVB outcome are significantly correlated, whereas the CRT was not predictive for treatment response.
 
[돌아가기]